The reaction of 5(4H)-oxazolones with tetraethyl methanediylbis(phosphonate) afforded new 1,1-bisphosphonate and 1,1-bisphosphonic acid derivatives. Moreover, 5(4H)-oxazolones reacted with Wittig reagents to give the corresponding heterocyclic products. Treatment of 5(4H)-oxazolones with trisdialkylaminophosphanes gave the corresponding N-(1-dialkylcarbamoyl)-2-phenylvinylbenzamides. Mechanisms accounting for the formation of the new products are discussed. The biological activity of the newly synthesized compounds was also examined.
Introduction
Bisphosphonates, especially the nitrogen-containing analogs, have been reported to be potent inhibitors of bone resorption and highly selective bone targeting agents [1 -3] . Moreover, nitrogen-, sulfur-or oxygencontaining five-and six-membered heterocyclic compounds have enormous significance in the field of medicinal chemistry. Oxazolones play a very vital role in the manufacturing of various biologically active drugs with analgesic [4] , anti-inflammatory [5] , antidepressant [6] , anticancer [7] , antimicrobial, antidiabetic, and anti-obesity activity [8, 9] . In view of this, and in continuation of our work in organophosphorus chemistry [10 -16] , it was of considerable interest to synthesize new 1,1-bisphosphonate, 1,1-bisphosphonic acid and heterocyclic oxazolone derivatives to obtain potent biologically active compounds.
The present study deals with the reaction of 5(4H)-oxazolones 1a -e with tetraethyl methanediylbis(phosphonate) (2) , phosphonium ylides 3a -c, and trisdialkylaminophosphanes 4a -b (Fig. 1 ).
Results and Discussion Chemistry
4-Benzylidene-2-phenyl-5(4H)-oxazolone (1a) was treated with two molar equivalents of tetraethyl methanediylbis(phosphonate) (2) in anhydrous dimethylformamide (DMF) solution using excess NaH as a base. After the reaction took place, dilute aqueous HCl was added to the reaction mixture at −5 • C. The crude Scheme 1. product was easily separated by solvent extraction and purified by column chromatography to give 1,1-bisphosphonate 5a as the major product (45 % yield) together with the phosphonate adduct 6a. Diethylphosphite was also identified (by TLC) (Scheme 1).
The most important feature of structure 5a is the presence of two signals at δ P = 23.16 (s) and 25.16 ppm (s) in its 31 P NMR spectrum. Moreover, the 1 H NMR spectrum of 5a (500 MHz) revealed three types of methine protons with different chemical shifts at δ H = 1.92 (ddd, J = 7 and 21.6 Hz, 1H, CH-P 2 ), 3.45, 3.47 (2 dd each set with J HH = 7.8 Hz, 3 J HP = 12 Hz, 1H, CHCH-P 2 ) and 4.38 ppm (dd, J = 7 and 6 Hz, 1H, cyclic CH). Also, 13 C NMR spectroscopy confirmed that both phosphorus atoms are attached to the same quaternary carbon atom [δ C = 25.3 (dd, J CP = 130 and 132 Hz, C-P 2 )]. The structure of 5a has also been assigned on the basis of elemental analysis and mass spectral data (cf. Experimental Section). Compound 6a (minor product, 25 % yield) was identified as diethyl 2-(4,5-dihydro-5-oxo-2-phenyloxazol-4-yl)-2-phenylvinylphosphonate on the basis of its IR, 1 H, 13 C, 31 P NMR and mass spectral data (cf. Experimental Section).
On the other hand, performing the reaction of 1a with 2 in concentrated hydrochloric acid instead of dilute acid led to the formation of bisphosphonic acid 7a as the main product (55 % yield), vinylphosphonic acid 8a (25 % yield) and phosphorus acid (Scheme 1). The structural assignments for compounds 7a and 8a are based upon elemental and spectroscopic data (IR, 1 H, 13 C, 31 P NMR and mass spectra) (cf. Experimental Section).
Similarly, when 1,3-oxazol-5(4H)-one 1b was reacted with bis(phosphonate) 2 using concentrated hydrochloric acid, bisphosphonic acid 7b (the major product) and phosphonic acid 8b were obtained. Phosphorus acid was also identified (TLC) in the reaction medium (Scheme 1). Structure elucidation of 7b and 8b was derived from their spectral data (cf. Experimental Section).
A possible explanation for the course of the reaction of 1a and 1b with 2 is shown in Scheme 1. 1,1-bisphosphonate 5a is possibly formed through a Michael addition [3, 17] of 2 to oxazolone 1a. Moreover, the phosphonate adduct 6a can result from a simple acid catalyzed elimination of diethyl phosphite from 5a (Scheme 1).
On the other hand, the substituted 1,1-bisphosphonic acids 7a, b and vinylphosphonic acids 8a, b were easily obtained via acid hydrolysis with concentrated HCl, which enabled the phosphonate ester to be removed to give directly 7a, b and 8a, b, respectively, with elimination of phosphorous acid (Scheme 1). Previous work has reported the synthesis of substituted 1,1-bisphosphonic acid through hydrolysis of the cor- Scheme 2. responding bisphosphonate product with concentrated hydrochloric acid [18] . The present study showed that substituted 1,1-bisphosphonic acids can be synthesized directly from the reaction of 4-arylidene-2-phenyl-5(4H)-oxazolone derivatives 1a, b with bisphosphonate 2 using concentrated hydrochloric acid (cf. Experimental Section).
Worthy to mention is that only one isomer of bisphosphonate 5a and the bisphosphonic acids 7a, b was isolated, suggested as syn configuration. The assigned syn configuration for these products, although not established with certainly, is supported by an inspection of a model drawn by Newman projection as well as by the chemical shifts and coupling constants of the exocyclic methine protons, and especially CH b -CH a -P, in their 1 H NMR spectra. The observed coupling constants of H b (J H b H a = J H b H c , ca. 6 -8 Hz) indicate the syn form, rather than the anti configuration which would give rise to larger coupling constants (9 -15 Hz).
Furthermore, this study was extended to include the behavior of oxazolones 1 towards phosphonium ylides 3a -c and tris(dialkylamino)phosphanes 4a, b to determine the preferential site of attack. We have found that when oxazolone 1a was allowed to react with two molar equivalents of ylides 3a and 3b in refluxing toluene, products 9a, b, 10a, b, 11a, b, triphenylphosphane, and unchanged oxazolone 1a were isolated. Carrying out the reaction using three instead of two molar equivalents of phosphonium ylides 3a, b under the same reaction conditions led to the formation of compounds 9a, b, 10a, b, 11a, b in good yields. Triphenylphosphane was also isolated in each case (Scheme 2).
Similarly, oxazolone 1c reacted with three molar equivalents of 3a, to give products 9c, 10c and 11c, respectively. Triphenylphosphane was also isolated (Scheme 2). Compounds 9a -c, 10a -c and 11a -c were obtained chromatographically pure by silica gel column chromatography and possess sharp melting points. Their structures were assigned based on elemental analysis, IR, 1 H, 13 C NMR and mass spectral data (cf. Experimental Section).
A possible explanation for the course of the reaction of 1a and 1c with the Wittig reagents 3a, b is shown in Scheme 2. Formation of products 9a -c presumably occurs via Michael addition of the ylide species 3a, b to the active methine carbon atom in oxazolones 1a and 1c to afford the intermediate A. Since triphenylphosphane is a good leaving group [19, 20] , Hofmann elimination [21] of triphenylphosphane followed by proton transfer leads to the final prod- Scheme 3. ucts 9a -c. Moreover, compounds 10a -c can be obtained by protonation of 1a, c at the carbanion center of ylides 3a, b to give the transient intermediate (B) followed by elimination of triphenylphosphane to afford 10a -c. It is worthy to mention that when compounds 9a -c were heated in toluene for 10 h, the bicyclic compounds 10a -c were obtained in 85 % yield. Compounds 11a -c may be regarded as products of an intramolecular Wittig reaction. Such addition-cyclization products apparently result from the addition of another ylide molecule 3a, b to the intermediate B followed by elimination of triphenylphosphane and the appropriate alcohol molecule under the applied reaction conditions to give the cyclic products 11a -c (Scheme 2).
Next, when oxazolone 1b was allowed to react with two molar equivalents of 3b, products 9d and 10d were obtained in good yield. Triphenylphosphane was also isolated and identified (Scheme 3). Moreover, when 1a and 1d were allowed to react with two molar equivalents of (triphenyl-λ 5 -phosphanylidene)acetonitrile (3c) in refluxing toluene, bicyclic dicarbonitrile 12, and 2-[2-phenyl-4-but-2-enedinitrile 13 were obtained. Triphenylphosphane and triphenylphosphane oxide were also isolated from the reaction mixture (Scheme 3). The structures of 9d, 10d, 12, and 13 have been confirmed on the basis of the full set of their spectral data (cf. Experimental Section). Also, when compound 1d reacted with one molar equivalent of 3a in refluxing toluene, methyl oxazol-5(4H)-ylidene)acetate 14 was obtained in 85 % yield. Triphenylphosphane oxide was also isolated.
Similarly, oxazolone 1e reacted with one molar equivalent of 3a in refluxing toluene, to give methyl oxazol-5(4H)-ylidene)acetate 15 in 82 % yield besides triphenylphosphane oxide (Scheme 3). The structure elucidation of compounds 14 and 15 was based on their analytical and spectral data (cf. Experimental Section).
The reactions of 4-arylidene-2-phenyl-5(4H)-oxazolones 1a, c, d with tris(dialkylamino)phosphanes 4a and 4b were also investigated. We have found that the reaction of 1a, c, d with one molar equivalent of each 1 and 4 in dry dichloromethane at r. t., affords the pure adducts formulated as 16a -f (Fig. 2) .
Products 16a -f were presumably formed via nucleophilic attack of 4a, b on the lactone carbonyl group in 1a, c, d followed by azalactone ring opening. Since dialkylaminophosphite is a good leaving group, compounds 16a -f can be formed through rapid hydrolysis due to the presence of unavoidable moisture (Scheme 4). The structures of compounds 16a -f were attested by their elemental analysis, IR, 1 H, 13 C NMR and mass spectral data (cf. Experimental Section).
It is worth mentioning that when 5(4H)-oxazolones 1a, c, d were allowed to react with a secondary amine, the same compounds 16a -f were obtained in good yields (cf. Experimental Section). 
Pharmacological evaluation
Cancer diseases are a serious threat to health and development of mankind, and the search for effective anti-cancer agents is a continuing challenge. Considerable progress has been made in recent years in the field of drug development against different types of cancer. Chemotherapy is a major approach for both localized and metastasized cancers [22] , and for many years oxazolone-related compounds have proved to have significant therapeutic potential [23] . Based on these considerations, five of the newly synthesized compounds were screened for their in vitro cytotoxic and growth inhibitory activities against human breast carcinoma cell line (MCF7), in comparison with the activity of the anticancer agent Doxorubicin (DXR) as a reference drug. The cytotoxic activities of the tested compounds were expressed as the median growth inhibitory concentration (IC 50 ) which is the dose that reduces survival to 50 %. The screening results are compiled in Table 1. According to the American National Cancer Institute guidelines [24] , drugs with IC 50 < 30 µg mL −1 are active. From Table 1 , it is evident that most of the tested compounds show anti-tumor activities with IC 50 values ranging from 19.3 -21.4 µg mL −1 .
The comparison of the cytotoxicity against MCF7 cells (Fig. 3 ) of the prepared compounds shows that the cell killing potency follows the order 10c = 12 > 13 > 9a > 9b. This may be attributable to the presence of the oxazolone moiety by contributing to the cytotoxic activity through interaction with DNA by intercalation and inhibition of the macromolecular biosynthesis. This inhibits the progression of the enzyme transcription topoisomerase II, which unwinds DNA for transcription and stabilizes the topoisomerase II complex after it has broken the DNA chain for replication, preventing the DNA double helix from being resealed. This process stops the replication in the same way as the Doxorubicin [25] suppressing agent, thus inhibiting the formation and growth of tumors from initiated cells [26] .
Antischistosomal activity of some compounds
It is well known that organophosphorus compounds are the most important group of pesticides due to their rapid metabolism [27] . On the other hand, oxazolone derivatives serve a wide range of pharmaceutical and biological purposes [28] , and they also possess insecticidal effects [29] . Therefore, this work aimed to prepare some oxazolone derivatives and to test (Table 3) . The results have shown that compound 16e possesses the strongest antischistosomal activity (IC 50 values equal to or less than 10 µg mL −1 ).
Conclusion
Based on the results of the present investigations, it could be concluded that tetraethyl methanediylbis-(phosphonate) (2), phosphonium ylides and tris(dialkylamino)phosphanes behave differently towards 2-aryl-5(4H)-oxazolones 1. While the reaction of 2 with oxazolones 1a, b resulted in the formation of the new 1,1-bisphosphonate, 1,1-bisphosphonic acid, and phosphonate derivatives, a different course was observed in the reaction of 1 with stabilized ylides 3 and tris(dialkylamino)phosphanes 4, depending on the nature of the addition products. A simple and direct method for the synthesis of substituted 1,1-bisphosphonic acids is also reported.
Some of the newly synthesized compounds were screened for their anticancer and antischistosomal activities. The compounds 9a, 9b, 10c, 12, and 13 revealed pronounced in vitro antitumor activities when tested against human breast cancer carcinoma cell lines (MCF7) in comparison with the anticancer agent Doxorubicin (DXR) as a reference. The most promising result against breast carcinoma (MCF7) was obtained by oxazoledicarbonitrile 12, oxazolemaleonitrile 13, and oxazole dicarboxylate 10c. They showed antitumor activities ranging from 19.3 -19.6 µg mL −1 . On the other hand, the antischistosomal activity of the compounds 16a -d, 16f showed that N-((1-dimethylcarbamoyl)-2-(3,4,5-trimethoxyphenyl) vinyl) benzamide 16e possesses in vitro antischistosomal activity (mortality 100 %, IC 50 values equal to or less than 10 µg mL −1 ). Compound 16e therefore is considered a promising bioactive compound which deserves further investigation.
Notably, clinical trials showed that high activity is observed for methylene-bisphosphonates with nitrogen-containing heteroaromatic substituents. Data on pharmacological potency of the new bisphosphonate will be published elsewhere.
Experimental Section
Melting points were determined in open glass capillaries using an Electrothermal IA 9100 series digital melting point apparatus (Electrothermal, Essex, UK), and IR spectra were measured from KBr pellets with a Perkin-Elmer Infracord spectrophotometer model 157. The 1 H and 13 C NMR spectra were recorded in CDCl 3 or [D 6 ]DMSO as solvent on a Jeol 500 MHz spectrometer, and the chemical shifts were recorded in δ values (ppm) relative to TMS as internal reference. The 31 P NMR spectra were taken on a Varian CFT-20 spectrometer in δ values (ppm) vs. external 85 % H 3 PO 4 as a standard. The mass spectra were performed at 70 eV on a Shimada GCS-OP 1000 Ex Spectrometer equipped with a data system. Elemental analyses were performed using an Elementar Vario E1 instrument. The values agreed favorably with calculated ones.
General procedure for reactions of 4-arylidene-2-phenyl-5(4H)-oxazolone (1a, 1b) with tetraethyl methanediylbis-(phosphonate) (2)
0.30 g (10 mmol) 80 % sodium hydride in 15 mL of anhydrous DMF was added slowly to a stirred solution of 2 (1.40 g, 5 mmol) in anhydrous DMF at 0 • C. After the addition was completed (1 h), a solution of 1a or 1b (2.5 mmol) in anhydrous DMF (10 mL) was added, and the resulting mixture was allowed to warm to room temperature and stirred for additional 0.5 -5 h (TLC), and then cooled again to −5 • C. HCl (1N) was added until pH was acidic; the mixture was extracted with CHCl 3 (3 × 50 mL). The combined organic phase was dried over anhydrous Na 2 SO 4 . After removal of the solvent under vacuum, the residue was chromatographed to give the products 5a and 6a. Also diethyl phosphite was identified (TLC).
Carrying out this reaction under the same conditions except adding conc. HCl instead of HCl (1N), 7a, b as the major products and 8a, b were separated. Also phosphorous acid was identified (TLC). -2-phenyl-4,5-dihydro-1,3-oxazol-4-yl) 
Tetraethyl [2-(5-oxo

Diethyl [2-(4,5-dihydro-5-oxo-2-phenyloxazol-4-yl)-2-phenylvinyl]phosphonate (6a)
Eluent
[2-(5-Oxo-2-phenyl-4,5-dihydro-1,3-oxazol-4-yl)-2-phenylethane-1,1-diyl]bis(phosphonic acid) (7a)
2-[(4,5-Dihydro-5-oxo-2-phenyloxazol-4-yl)-2-phenylvinyl]phosphonic acid (8a)
[2-(4-Nitrophenyl)-2-(5-oxo-2-phenyl-4,5-dihydro-1,3-oxazol-4-yl)ethane-1,1-diyl]bis(phosphonic acid) (7b)
[2-(4-Nitrophenyl)-2-(5-oxo-2-phenyl-4,5-dihydro-1,3-oxazol-4-yl)ethenyl]phosphonic acid (8b)
Eluent: petroleum ether-acetone (95/5, v/v). Product 8b was separated as yellow crystals, yield 20 %. - 
General procedure for reactions of 4-arylidene-2-phenyl-5(4H)-oxazolones (1a, 1c) with carbalkoxymethylene triphenylphosphoranes (3a, 3b)
One mmol of 1a or 1c was added to 3 mmol of 3a or 3b, and the mixture was refluxed in 30 mL of dry toluene for 5 -7 h. The volatile materials were evaporated under reduced pressure. The residue was subjected to silica gel column chromatography to give the products 9a -c, 10a -c and 11a -c. Triphenylphosphane was also isolated from the reaction medium and identified (mixed m. p., MS). Products 9a -c were refluxed in dry toluene to give products 10a -c (cyclic form) in 85 % yield. [3,2-d] [1, 3] [3,2-d] [1, 3] 
Methyl 3-(4,5-dihydro-5-oxo-2-phenyloxazol-4-yl)-3-phenylacrylate (9a)
Methyl (5-oxo-2,7-diphenyl-5H-pyrano[3,2-d][1,3]oxazol-6(7H)-ylidene)ethanoate (11a)
Ethyl (5-oxo-2,7-diphenyl-5H-pyrano
Methyl 6-[4-(dimethylamino)phenyl]-2-phenyl-5,6-dihydrofuro[3,2-d][1,3]oxazole-5-carboxylate (10c)
Methyl {7-[4-(dimethylamino)phenyl]-5-oxo-2-phenyl-5H-pyrano
Reaction of 4-(4-nitrobenzylidene)-2-phenyl-1,3-oxazol-5(4H)-one (1b) with ethyl (triphenyl-λ 5 -phosphanylidene)-acetate (3b)
0.29 g (1 mmol) of 1b was added to 0.7 g (2 mmol) of 3b, and the mixture was allowed to reflux in 30 mL dry toluene for 10 h (TLC). The volatile materials were evaporated under reduced pressure. The residue was chromatographed to give the products 9d and 10d. Triphenylphosphane was also isolated from the reaction medium and identified (mixed m. p., MS). 
General procedure for reactions of 4-arylidene-2-phenyl-1,3-oxazol-5(4H)-ones (1a, d) with (triphenyl-λ 5 -phosphanylidene)acetonitrile (3c)
A mixture of 1a, d (1 mmol) and 3c (0.60 g, 2 mmol) in 30 mL of dry toluene was refluxed for 7 -10 h (TLC).
The volatile materials were evaporated under reduced pressure. The residue was chromatographed to give products 12 and 13. Triphenylphosphane and triphenylphosphane oxide were also isolated from the reaction mixture and identified (mixed m. p., MS). 3H, s, CH 3 ), 3.9 (9H, s, 3 OCH 3 ), 6.2 (1H, s, C=CH 
(
General procedure for reactions of 4-arylidene-2-phenyl-1,3-oxazol-5(4H)-ones (1a, c, d) with tris(dialkylamino)-phosphanes (4a, b)
A mixture of 1a, c, d (1 mmol) and tris(dialkylamino)-phosphanes 4a, b (1 mmol) in dry dichloromethane (30 mL) was stirred at r. t. for 5 -10 h (TLC). The volatile materials were evaporated under reduced pressure. The residue was washed with boiled cyclohexane to give the products 16a -f in pure form.
General procedure for reactions of 4-arylidene-2-phenyl-1,3-oxazol-5(4H)-ones (1a, c, d) with secondary amines
4-arylidene-2-phenyl-1,3-oxazol-5(4H)-ones 1a, c, d (1 mmol) and diethylamine or dimethylamine (1 mmol) were warmed for few seconds until complete fusion. The reaction mixture was washed with boiled cyclohexane to give the products 16a -f in good yields (m. p., mixed m. p. and comparative IR). 
N-[(1-dimethylcarbamoyl)-2-phenylvinyl]benzamide (16a)
